Vanguard Capital Management
ARMP icon

Vanguard Capital Management’s Armata Pharmaceuticals ARMP Stock Holding History

Vanguard Capital Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Buy
487,968
+121,940
+33% +$1.12M ﹤0.01% 3273
2026
Q1 		$3.75M Buy
+366,028
New +$3.08M ﹤0.01% 3164

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Vanguard Capital Management's ARMP Position: Q2 2026 in Review

Vanguard Capital Management increased its Armata Pharmaceuticals (ARMP) stake by 33% in Q2 2026, buying an estimated $1.12M and bringing the position to 487,968 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3273.

Vanguard Capital Management first reported a position in ARMP in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.75M in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Vanguard Capital Management held 487,968 shares of Armata Pharmaceuticals worth $3.16M as of Q2 2026.
  • Vanguard Capital Management bought 121,940 Armata Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
  • Armata Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3273 holding.
  • Vanguard Capital Management first reported a position in Armata Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Armata Pharmaceuticals position peaked at $3.75M in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.